Actively Recruiting
The Longitudinal Approach to Acromegaly: A Pattern of Treatment and Comparative Effectiveness Research
Led by Ginkgo Leaf Center for Rare Disorders · Updated on 2022-03-16
1965
Participants Needed
1
Research Sites
1728 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study is a prospective, noninteractive, observational, and longitudinal study aimed at assessing the treatment pattern and clinical outcome of acromegaly in China.
CONDITIONS
Official Title
The Longitudinal Approach to Acromegaly: A Pattern of Treatment and Comparative Effectiveness Research
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Able and willing to sign the informed consent form
- Male or female aged 18 to 75 years old (including 18 and 75)
- Diagnosed with acromegaly confirmed by at least one random growth hormone measurement ≥ 2.5 µg/L
- Radiographic evidence of a pituitary tumor shown in at least one medical record or checklist
You will not qualify if you...
- Ectopic secretion of growth hormone or pituitary cancer
- Diagnosed with other malignancies or having residual lesions from previous cancers
- Having severe acute or chronic medical or psychiatric conditions that increase study risks or interfere with study results
- Considered inappropriate for enrollment by the Investigator
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
China Acromegaly Organization
Guangzhou, Guangdong, China, 510000
Actively Recruiting
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here